Article ID Journal Published Year Pages File Type
5501135 Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2017 9 Pages PDF
Abstract

•A peptide based MG scavenger with excellent pharmacokinetic properties was developed.•The scavenging efficacy and the molecular mechanism of action were demonstrated in vivo.•The toxic metabolite MG was excreted upon binding to the scavenger.

The reactive metabolite methylglyoxal (MG) has been identified as mediator of pain. Scavenging of free MG and the prevention of MG-derived post-translational modifications may provide a useful therapeutic treatment. An arginine-rich, fatty acid coupled, cyclic peptide (CycK(Myr)R4E) with high proteolytic stability and prolonged circulation was developed for the scavenging of MG. It was shown to reduce the formation of albumin-MG adducts in vitro and prevented MG-induced pain by reducing plasma MG levels through the formation of peptide-MG adducts in vivo. CycK(Myr)R4E therefore presents a promising option for the treatment of pain and other diabetic complications associated with high MG levels.

Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Ageing
Authors
, , , , , , , , , , , ,